Navigation Links
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Date:4/24/2009

moderately to severely active rheumatoid arthritis
  • Alone or in combination with methotrexate for the treatment of adult patients with active psoriatic arthritis
  • For the treatment of adult patients with active ankylosing spondylitis

  • SIMPONI is available in two dosage forms. The SIMPONI SmartJect(TM) is a novel autoinjector designed to meet the needs of arthritis patients that has received the Ease-of-Use Commendation by the Arthritis Foundation. SIMPONI is also available as an easy to use prefilled syringe.

    The efficacy and safety of SIMPONI have been evaluated in one of the most comprehensive clinical development programs for an anti-TNF-alpha therapy, which included simultaneous studies in rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis. The program, which includes more than 2,000 patients across five pivotal Phase 3 trials, served as the primary basis for FDA approval. In rheumatoid arthritis, SIMPONI has been studied in a broad range of patients, including adults naive to methotrexate, adults responding inadequately to methotrexate and adults previously treated with at least one anti-TNF-alpha agent. In each of the three trials, significantly more patients receiving SIMPONI 50 mg plus methotrexate achieved at least a 20 percent improvement in arthritis symptoms (ACR20), compared with patients receiving placebo plus methotrexate and/or other disease modifying anti-rheumatic drugs. Improvements were seen as early as four weeks after the first SIMPONI injection and continued to improve over time. A proportion of patients also achieved substantial improvements in arthritis symptoms, 50 percent improvement (ACR50) and 70 percent improvement (ACR70), with continued SIMPONI treatment.

    A Phase 3 trial, the largest of its kind, evaluating SIMPONI in the treatment of psoriatic arthritis showed that SIMPONI 50 mg significantly improve
    '/>"/>

    SOURCE Centocor Ortho Biotech Inc.
    Copyright©2009 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9

    Related medicine news :

    1. Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
    2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
    3. DaVita Receives Civil Complaint
    4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
    5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
    6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
    7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
    8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
    9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
    10. Prime Therapeutics Receives TIPPS Certification
    11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/30/2015)... ... July 30, 2015 , ... Dale Sky Jones, Executive Chancellor of ... the International Cannabis Professionals Expo held at the Caribe Royal All Suites Hotel and ... Professionals Expo is the largest medical cannabis expo in the country and this ...
    (Date:7/30/2015)... ... 31, 2015 , ... The Venetian on Grace Bay in the Turks & Caicos Islands is ... Venetian will save 40% on their stay while enjoying some of the most beautiful ocean ... & Caicos, providing a chance to reconnect with loved ones and rediscover one's best self. ...
    (Date:7/30/2015)... ... July 31, 2015 , ... Committed to helping the ... by asking community members to contribute to the College’s “My Brother’s Keeper Scholarship.” The ... young people stay on track. Providing the support they need to think more broadly ...
    (Date:7/30/2015)... Sierra Madre, CA (PRWEB) , ... July 30, 2015 , ... ... wound care programs, the activity of recruiting patients becomes a serious challenge. Because of ... wound care program to patients within the local community. , The team at ...
    (Date:7/30/2015)... ... July 30, 2015 , ... OSF Healthcare System has been ... Most Wired Survey conducted by Hospitals & Health Networks. This marks the fourth consecutive ... by The Sisters of the Third Order of St. Francis . , Health ...
    Breaking Medicine News(10 mins):Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 2Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 3Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 4Health News:Finally…First Ever Professional Training Event for Doctors and Nurses Wanting to Offer Medical Marijuana Recommendations to Patients 5Health News:The Venetian on Grace Bay in Turks & Caicos Islands Offers 40% Savings This Fall. 2Health News:Mercy College a “My Brother’s Keeper” Community 2Health News:Mercy College a “My Brother’s Keeper” Community 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 2Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 3Health News:WCA Offers Shockwave; The Marketing Module for Hospital Wound Care Programs 4Health News:OSF HealthCare Named One of the Most Wired Systems 2Health News:OSF HealthCare Named One of the Most Wired Systems 3
    ... Cytori Therapeutics (NASDAQ: CYTX) announced today the ... European Journal of Surgical Oncology. , ... trial using autologous adipose-derived regenerative cell (ADRC)-enriched fat ... surgery. The majority of patients underwent radiation prior ...
    ... sudden hearing loss, a frightening condition that sends thousands in ... this month in the journal OtolaryngologyHead and Neck Surgery ... led by Robert J. Stachler, M.D., an otolaryngologist in the ... in Detroit. "In most cases, patients will have ...
    ... , MONDAY, March 19 (HealthDay News) -- The emergency room ... blackouts can be more than half a million dollars a ... new study found. The University of Wisconsin-Madison ... the 28 days before the start of the study, male ...
    ... of Granada researchers have developed a software tool that ... person has to suffer a heart disease. In addition, ... estimations, i.e. it helps estimating the risk that a ... The researchers employed a sample including 3 000 patients. ...
    ... March 17 (HealthDay News) -- People who follow seven ... die than those who follow few or none of ... 45,000 U.S. adults. However, the researchers also found ... recommended by the American Heart Association (AHA), which include: ...
    ... 17 (HealthDay News) -- Teens and young adults who binge ... be risking brain damage, an expert warns. Binge drinking, ... drinks by males and three drinks by females in a ... said Dr. Alicia Ann Kowalchuk, medical director of the InSight ...
    Cached Medicine News:Health News:Cytori breast reconstruction cell therapy trial results published 2Health News:First national guideline for sudden hearing loss published 2Health News:Excessive Drinking Costs U.S. Colleges Millions Annually 2Health News:Scientists develop a software tool for estimating heart disease risk 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 2Health News:Following Heart-Healthy Behaviors May Lengthen Your Life 3Health News:Spring Break Boozing May Put Young Brains at Risk 2
    (Date:7/30/2015)... , July 30, 2015  Cleveland Clinic President ... keynote address last month that industry is compelled to ... to gain the efficiencies—and develop the transformational innovations -- ... Barsoum,s comments were preceded by Doug Kohrs , ... OMTEC moderator, who stressed that industry must add "episode ...
    (Date:7/30/2015)... FAIRFIELD, N.J. , July 30, 2015 /PRNewswire/ ... Ferrer, completed the second Phase III clinical study ... development for impetigo.  Medimetriks owns the exclusive U.S. ... The global trial, conducted at 44 centers with ... and pediatric patients aged 2 months and older ...
    (Date:7/30/2015)... Calif. , July 30, 2015   ... to eliminate all preventable hospitalization, recently received confirmation ... its Remote Patient Intelligence (RPI) solution meets the ... FDA intends to exercise "Enforcement Discretion." ... not subject to further FDA regulatory requirements at ...
    Breaking Medicine Technology:Orthopaedic Surgery Reimbursement Shifts to Episode of Care 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 2Medimetriks Pharmaceuticals, Inc. Announces Completion of the Second Successful Pivotal Phase III Study for Ozenoxacin 3FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 2FDA Clears Way for Commercial Marketing of Sentrian Remote Patient Intelligence Solution 3
    Minimal M9CA Broth...
    An agent used for making solid microbiological media....
    ... of miniTHERM incubators is available, ensuring the ... for their specific requirements. miniTHERM incubators have ... and extremely space saving. Their size corresponds ... is possible to stack up to three ...
    In microbiological laboratories and for in vitro fertilization, as well as in cancer research or tissue engineering, the Heraeus CO2 incubator BBD 6220 provides the best contamination protection and ...
    Medicine Products: